Stockholm - Delayed Quote SEK

Karolinska Development AB (publ) (KDEV.ST)

Compare
1.4900 +0.0080 (+0.54%)
At close: 5:24 PM GMT+2
Loading Chart for KDEV.ST
DELL
  • Previous Close 1.4820
  • Open 1.4820
  • Bid 1.4900 x --
  • Ask 1.4960 x --
  • Day's Range 1.4620 - 1.5020
  • 52 Week Range 1.4100 - 1.9480
  • Volume 200,767
  • Avg. Volume 176,672
  • Market Cap (intraday) 402.051M
  • Beta (5Y Monthly) 0.24
  • PE Ratio (TTM) 12.42
  • EPS (TTM) 0.1200
  • Earnings Date Aug 30, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

www.karolinskadevelopment.com

8

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KDEV.ST

Performance Overview: KDEV.ST

Trailing total returns as of 6/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

KDEV.ST
12.25%
OMX Stockholm 30 Index
6.69%

1-Year Return

KDEV.ST
7.22%
OMX Stockholm 30 Index
10.16%

3-Year Return

KDEV.ST
41.68%
OMX Stockholm 30 Index
11.90%

5-Year Return

KDEV.ST
55.95%
OMX Stockholm 30 Index
60.95%

Compare To: KDEV.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KDEV.ST

Valuation Measures

Annual
As of 6/14/2024
  • Market Cap

    399.89M

  • Enterprise Value

    324.50M

  • Trailing P/E

    12.27

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    206.45

  • Price/Book (mrq)

    0.32

  • Enterprise Value/Revenue

    167.53

  • Enterprise Value/EBITDA

    61.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1,734.95%

  • Return on Assets (ttm)

    -1.44%

  • Return on Equity (ttm)

    2.73%

  • Revenue (ttm)

    1.94M

  • Net Income Avi to Common (ttm)

    33.61M

  • Diluted EPS (ttm)

    0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    67.48M

  • Total Debt/Equity (mrq)

    0.23%

  • Levered Free Cash Flow (ttm)

    -6.64M

Research Analysis: KDEV.ST

Company Insights: KDEV.ST

Research Reports: KDEV.ST

People Also Watch